Latest News

Power Corporation of Canada announced that long-time leader R. Jeffrey Orr has moved into the Vice-Chair role, with James O'Sullivan, currently President and CEO of subsidiary IGM Financial, succeeding him as President and CEO of the Corporation effective July 1, 2026. This move elevates a leader deeply embedded across Power’s wealth, asset management and fintech platforms, potentially reinforcing the group’s focus on integrated financial services. We’ll now examine how elevating IGM...

Why DF Deutsche Forfait (XTRA:DFTK) just jumped onto traders’ radar DF Deutsche Forfait (XTRA:DFTK) drew attention after a sharp intraday price surge on 16 February 2026, accompanied by heavy trading volume ahead of its scheduled earnings announcement on 28 April 2026. See our latest analysis for DF Deutsche Forfait. That sudden jump in trading interest sits on top of a very strong run, with the share price at €8.15 and multi month share price returns many times higher than earlier levels,...

If you are wondering whether Diodes at around US$67.54 is a bargain or already fully priced, you are in the right place for a closer look at what the current share price might imply. The stock has seen sharp moves recently, with returns of 9.5% over the last 7 days, 18.7% over 30 days, 31.3% year to date and 22.5% over the last year, compared with longer term returns of a 23.9% decline over 3 years and a 15.4% decline over 5 years. Recent news coverage has focused on Diodes as part of...

If you are wondering whether New Gold's recent run has already priced in the opportunity, or if there is still value left on the table, this article is for you. The share price closed at C$14.72, with a year to date return of 25.0% and a 1 year return of 251.3%, even after a 4.1% decline over the last week and a 4.4% decline over the last month. Recent news flow around New Gold has focused on the company as a leveraged way to gain exposure to gold prices and on how its share price...

P/F Bakkafrost has reported its fourth-quarter 2025 results, with sales rising to DKK 1,846.9 million and net income to DKK 582.8 million, while full-year 2025 sales eased to DKK 7,007.15 million and net income to DKK 517.35 million. The company also declared a DKK 3.45 per share cash dividend approved on 30 April 2026, offering fresh insight into how it is balancing shareholder returns with a year of weaker overall earnings. Next, we’ll examine how Bakkafrost’s stronger quarterly...

If you are looking at Black Stone Minerals and wondering whether the current price offers solid value, this article will walk you through what the numbers are really saying. The stock last closed at US$15.25, with returns of 0.7% over 7 days, 8.2% over 30 days, 12.9% year to date, 12.0% over 1 year, 34.1% over 3 years and a very large gain over 5 years of 169.4%. Recent price moves sit against a backdrop of ongoing investor interest in energy royalty and mineral rights businesses. In these...

Hapag-Lloyd (XTRA:HLAG) has agreed to acquire 100% of Zim Integrated Shipping Services in a deal valued at more than US$4b. The transaction involves cooperation with FIMI Opportunity Funds and is structured at a significant premium to Zim’s recent trading levels. The deal is subject to regulatory, shareholder, and national security approvals, including in Israel, and may lead to Zim being delisted from the NYSE. If completed, the combined group would rank as the fifth-largest container...

If you are wondering whether Saipem shares are offering solid value at today’s price, you are in the right place. This article will walk through how that value story stacks up using several different lenses. Saipem’s share price recently closed at €3.39, with returns of 4.9% over the past week, 23.9% over the past month, 35.5% year to date and 56.5% over the last year, set against a 43.2% decline over five years. These moves have come as investors refocus on Saipem’s position in the energy...

IRADIMED (NasdaqGM: IRMD) declared a regular quarterly cash dividend. The company reported earnings results for the fourth quarter of 2025. IRADIMED also released its financial results for the full year 2025. IRADIMED, trading at $100.625, has seen its share price climb 79.4% over the past year and 378.2% over the past five years. This performance puts recent results and the new dividend in sharp focus for existing and prospective shareholders. The stock is also up 5.4% year to date, even...

Wondering if Upwork at around US$12.76 is a bargain or a value trap? This article walks through what the current price might be implying about the business. The stock has seen sharp moves recently, with a 12% decline over the last week, a 35.8% decline over the last month, and a 35.7% decline year to date, while the 3 year return sits at 8% and the 5 year return at a 76.1% decline. Recent headlines have focused on Upwork as a key listed platform in the online freelance and remote work space,...

Wondering if Winnebago Industries is a bargain at its current share price or if the stock already reflects its prospects? This article breaks down what the numbers actually say about value. The stock last closed at US$46.65, with a year to date return of 14.2% and a 1 year gain of 9.0%, after 30 day and 7 day returns of 2.4% and 1.2% declines respectively, so recent trading has been mixed. Recent headlines around Winnebago have focused on broad themes like consumer demand for outdoor...

AMC Entertainment Holdings (AMC) has filed an omnibus shelf registration that covers a wide range of securities, along with a separate at the market follow on offering of up to US$150 million in common stock. See our latest analysis for AMC Entertainment Holdings. These capital raising plans land after a tough stretch for shareholders, with AMC’s latest share price at US$1.25, a 30 day share price return of 22.36% decline and a 1 year total shareholder return of 66.22% loss. This suggests...

KandenkoLtd (TSE:1942) shares are in focus after the company announced a planned overhaul of its leadership, including the retirement of representative director Yuji Ueda, as it shifts to a new management structure. See our latest analysis for KandenkoLtd. The leadership overhaul comes after a strong run for investors, with the share price at ¥6,688 and a 90 day share price return of 37.87%, while the 1 year total shareholder return sits at 161.88%, indicating powerful momentum that has built...

If you are wondering whether Conagra Brands at around US$18.89 is a bargain or a value trap today, this article will help you assess what the current share price really reflects. The stock has recently shown mixed returns, with an 11.4% gain over 30 days and 9.2% year to date, set against a 15.0% decline over 1 year and a 38.7% decline over 3 years. Recent coverage has focused on how Conagra Brands fits into the packaged foods sector, including commentary on its brand portfolio and cost...

Tokyo Ohka Kogyo Co., Ltd. recently reported full-year 2025 results showing higher sales and profit, raised its 2027 earnings guidance on stronger generative AI-related demand and a weaker yen, and announced an increased cash dividend of ¥37.00 per share for 2025 with expectations for higher dividends in 2026. The upward revision of the “tok Medium-Term Plan 2027” highlights how generative AI demand is reshaping the company’s core electronics materials business and earnings outlook. We’ll...

Humana’s CenterWell has acquired MaxHealth, a primary care provider in Florida. The deal significantly broadens CenterWell’s primary care presence across the state. The acquisition supports Humana’s value based care model for Medicare and other patients. For investors watching NYSE:HUM, this move comes with the stock trading around $184.99 and showing mixed recent performance. Shares are up 2.0% over the past week but have seen declines of 32.3% over 30 days and 30.1% year to date. Over...

In recent days, Oracle has secured new public-sector and healthcare cloud deals, expanded its AI-driven software and clinical tools, and won an US$88 million United States Department of the Air Force cloud contract, even as it faces multiple securities fraud class action lawsuits over its AI infrastructure spending disclosures. These developments highlight a sharp contrast between Oracle’s expanding role in mission-critical AI and cloud workloads and growing investor unease about its heavy...

Valero Energy (VLO) is back in focus after securing discounted Venezuelan crude, as U.S. policy shifts and sanctions ease. This development gives the refiner access to lower cost supply and supports recent margin strength. See our latest analysis for Valero Energy. Over the past year, Valero Energy’s share price return has been supported by strong refining margins and discounted Venezuelan crude, with a 30 day share price return of 7.57% and a 1 year total shareholder return of 47.0%,...

In February 2026, Nitto Boseki Co., Ltd. reported past nine‑month results showing higher sales of ¥87,594 million and sharply higher net income of ¥35,110 million year on year, and it raised full‑year guidance to operating profit of ¥20,000 million and profit attributable to owners of parent of ¥38,000 million. The upgrade to full‑year profit targets, alongside much stronger earnings per share of ¥964.42 over nine months, signals management’s confidence in the company’s current business...

What Capital One Financial (COF) investors are watching now Capital One Financial (COF) has been trading under pressure recently, with the stock down about 13% over the past month and modestly positive over the past 3 months, which has drawn fresh attention to its valuation. See our latest analysis for Capital One Financial. Despite the recent 13.6% 30 day share price decline and a 6% drop over the past week, Capital One Financial’s 1 year total shareholder return of 2.9% and very large 3...

Recent performance snapshot Revolution Medicines (RVMD) has drawn investor interest after recent price moves, with the stock closing at $100.61 and showing mixed short term returns, including a pullback over the past month and comparatively stronger performance over the past 3 months. See our latest analysis for Revolution Medicines. Looking beyond the recent swings, Revolution Medicines has paired a sharp 42.65% 90 day share price return with a very large 1 year total shareholder return of...

Earlier this week, Citigroup initiated coverage of Adecoagro S.A. with a Buy rating, highlighting supportive fundamentals and its exposure to agricultural commodity markets, while Zacks ranked the stock #1 (Strong Buy) with an A grade in Value based on its valuation metrics. Together, the fresh analyst coverage and value-oriented recognition frame Adecoagro as a company where perceived mispricing and business positioning are attracting heightened institutional attention. We’ll now examine...

If you are wondering whether K92 Mining's share price still reflects fair value after a strong run, this article will walk through what the numbers are actually saying about the stock. The share price recently closed at C$27.32, with returns of 4.6% over 30 days, 21.5% year to date and 163.7% over the past year, which can change how investors think about both upside and risk. Recent coverage has focused on K92 Mining's position as a gold producer listed on the TSX, with investors paying...

Hims & Hers Health (NYSE:HIMS) has halted its newly launched compounded GLP-1 weight loss pill only days after introducing it. The move follows a lawsuit from Novo Nordisk over compounded weight loss drugs and increased FDA scrutiny of these products. The company is shifting its focus toward longevity and diagnostics, including hormone therapy and early cancer detection services. Hims & Hers Health, known for its direct to consumer telehealth model across categories like mental health, hair...